The PERT Consortium®
@PERTConsortium
Followers
6K
Following
7K
Media
2K
Statuses
4K
We exist to increase awareness of treatment options available to patients with PE, to reduce the worldwide incidence of PE, and to further scientific discovery
Joined October 2014
One of our #bruinhearts more memorable (attempted) TEE+ cardioversions... What was a routine case became a fantastic #echofirst learning opportunity & a completely unexpected turn in @JACCJournals #JACCCaseReports By #abhinavthummala #saminatour
https://t.co/DDEK7cKakW 🧵 1/
3
12
26
We are proud to announce our first international PE Center of Excellence, King Fahad Medical City in Saudi Arabia! This prestigious designation recognizes KFMC’s outstanding commitment to evidence-based care, multidisciplinary collaboration, and advancing patient outcomes in
2
19
28
**FINAL CALL FOR PROPOSALS** The PERT Consortium® is calling all researchers, authors, and investigators to submit their pulmonary embolism research proposals. Accepted proposals will be pursued by the PERT Research Committee, in collaboration with the submitting researcher.
0
2
4
Missed our live webinar? Watch More Clot. Less Time. Full Control: The Next Chapter in PE Intervention at your convenience. Dr. Vivian Bishay, National Co-Principal Investigator of the SYMPHONY-PE Study, leads a dynamic panel covering unmet needs in PE care, trial insights,
0
1
5
TONIGHT! Join Our Live Webinar (In Collaboration with the American Venous Forum | AVF): Evolving Data and Innovative Approaches for PE Management with CAVT™ Wednesday, November 12, 2025 8:00 PM ET There’s still time to join us live for an in-depth discussion on the latest data
0
0
0
US HCPs: Interested in the future of PE care? Join Drs. James Benenati, Suhail Dohad, Patrick Muck, Parag Patel, and Rachel Rosovsky on November 12th as they share evolving data & innovative approaches for PE management with #CAVT. Register here: https://t.co/ePs0XBVgIu
0
6
10
The PERT Consortium® is calling all researchers, authors, and investigators to submit their pulmonary embolism research proposals. Accepted proposals will be pursued by the PERT Research Committee, in collaboration with the submitting researcher. Proposals may seek to leverage
forms.office.com
The PERT Consortium® is calling all researchers, authors, and investigators to submit their pulmonary embolism research proposals. Accepted proposals will be pursued by the PERT Research Committee,...
0
0
3
Be part of the conversation shaping the future of #pulmonaryembolism care. Join #PE experts as they share the latest clinical insights & perspectives on upcoming randomized controlled trials that are expected to transform PE treatment. 👉 Register today: https://t.co/7joQ3lb6LL
0
5
3
First Commercial Cases — The AVENTUS Thrombectomy System has officially entered clinical practice. We are proud to celebrate this milestone alongside Dr. Jun Li at University Hospitals, Dr. Fabio Komlos at El Camino Health, Dr. Brian Stegman at CentraCare, and Dr. Samuel Horr at
0
1
1
Announcing Our Upcoming PE Webinar (In Collaboration with the American Venous Forum | AVF): Evolving Data and Innovative Approaches for PE Management with CAVT™ Wednesday, November 12, 2025 8:00 PM ET Tune in to this upcoming webinar to hear from key opinion leaders in
0
1
2
A sincere 𝐭𝐡𝐚𝐧𝐤 𝐲𝐨𝐮 to the organizers and attendees of the incredible meetings we have been part of over the past several weeks — #CritCareCards25, #CHEST2025, #TCT2025, and #VIVA25. We are incredibly grateful for the opportunity to collaborate, share insights, and
0
0
2
Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes from the STORM-PE Trial | Circulation
ahajournals.org
Background: Patients with intermediate-high risk pulmonary embolism (PE) have an elevated right-to-left-ventricular (RV/LV) diameter ratio and are at risk of early clinical decompensation and...
0
11
20
#VIVA25 #PERT Late-Breaking Deep Dive Session with top PE experts and thought leaders driving innovation in PE care! @RosovskyRachel @EricSecemskyMD @krosenfieldMD @JonnyMoriarty
0
4
12
Breaking news! @RosovskyRachel announced the PE- Storm Trial first and secondary results just published.
1
8
17
Another incredible moment for PE-Storm at #VIVA25! Honored to have partnered with @PenumbraInc on this groundbreaking trial—paving the way for new standards in pulmonary embolism treatment and outcomes. Congratulations @RosovskyRachel @roblookstein
0
4
11